30-day mortality was computed in the NCDB by subtracting the "date of last contact or death" from the date of surgery and assessing the patient vital status (alive or dead) on the latter date.
The use of the NCDB allowed us to capture a great proportion of newly diagnosed cases of kidney cancer in the United States, providing robust estimates of associations that are generalizable.
Lastly, since the NCDB is not a database specific to urological cancer care, we could not ascertain urology-specific predictors and outcomes.
Since hospitals included in the NCDB exhibit higher levels of cancer specialization than other hospitals, our findings may demonstrate the best-case scenario in terms of contemporary IO utilization.
Since the NCDB does not code IO as a unique treatment, we used lack of treatment to define IO.
Among other things, the new version of the NCDB will greatly help us in our fast expansion to other countries seeing that we can start using its very advanced features within a matter of weeks on these new markets,” said Radek Klein, IT manager of GTS ALIVE, in relation to the new project realization.
This feature will significantly ease NCDB implementation in new partner countries.
Patients treated at Baylor Sammons Cancer Center from 2003 to 2009 received treatment in accordance with the NCCN guidelines, with survival outcomes similar to those published in the NCDB
Care Communications is in place to support cancer registrars from across the country through each step of the NCDB
data receipt process, including data submission, edits, corrections, and report administration.
Using the Louis Stokes Cleveland VA Medical Center license, aggregate data from the NCDB was accessed through the Hospital Comparison Benchmark Reports, a web-based application on the CoC's Datalinks portal.
Using the classification system employed by the CoC, approved hospitals were categorized as: community cancer programs; comprehensive community cancer programs; teaching/research programs; Veterans Affairs (VA) cancer programs; and "other" low-volume cancer programs, which typically report fewer than 100 cases annually to the NCDB.
A clear strength of our study is the comprehensiveness of the NCDB, which captures over 70% of incident cancers in the United States, regardless of age, and distinguishes EM from hormonal therapy.